e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation
R. A. Jörres, D. Loppow, E. Huland, H. Heinzer, L. Grönke, O. Holz, H. Magnussen (Grosshansdorf, Hamburg, Germany)
Source:
Annual Congress 2003 - Asthma
Session:
Asthma
Session type:
Thematic Poster Session
Number:
3021
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. A. Jörres, D. Loppow, E. Huland, H. Heinzer, L. Grönke, O. Holz, H. Magnussen (Grosshansdorf, Hamburg, Germany). Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation. Eur Respir J 2003; 22: Suppl. 45, 3021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin
Source: Eur Respir J 2004; 24: Suppl. 48, 6s
Year: 2004
Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
IL-33 and airway remodelling in paediatric severe therapy resistant asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 569s
Year: 2002
Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Correlation between airway inflammation and loss of deep inhalation bronchoprotection in asthmatics
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004
Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept